Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

Featuring perspectives from Dr Emmanuel S Antonarakis and Prof Karim Fizazi, including the following topics:

• Introduction: Quality of Life (0:00)
• PARP Inhibition (PARPi) (7:15)
• M0 Disease (23:18)
• Metastatic Hormone-Sensitive Prostate Cancer (34:33)
• Radiopharmaceuticals (46:16)
• Other Novel Investigational Approaches for Metastatic Castration-Resistant Prostate Cancer (54:53)

CME information and select publications